Skip to main content
. 2015 Sep 18;59(10):6132–6139. doi: 10.1128/AAC.00486-15

TABLE 1.

Enterococcus faecium strains used in this study

Strain Reference Genotype MICa
CPT (mg/liter) COL (mg/liter) PB (mg/liter) DAP (mg/liter) LL-37 (μM)
D344R 9 Wild-type E. faecium 32 128 128 4 32
D344S 10 Δpbp5 (ΔPBP5) derivative of D344R 32 >256 192 3 32
CV536 11 ΔpbpF (ΔPBP3) derivative of D344R 32 >256 256 2 32
CV537 11 ΔpbpZ (ΔPBP2) derivative of D344R 8 192 192 2 8
CV551 11 ΔpbpF ΔpbpZ derivative of D344R 32 192 128 1 8
CV558 11 ΔpbpF ΔponA derivative of D344R 32 256 192 1.5 32
CV598 11 ΔpbpF ΔpbpZ ΔponA derivative of D344R 16 48 48 1 16
CV571/pCWR1686 11 ΔponA (ΔPBP1) (cv558 complemented with pbpF plasmid; Kmr) 16 192 192 2 8
8019 6 Contemporary vancomycin-resistant E. faecium NP NP NP 0.38 2
a

CPT, ceftaroline (broth microdilution); COL, colistin (Etest); PB, polymyxin B (Etest); DAP, daptomycin (Etest); LL-37 (broth microdilution). NP, not performed. Kmr, kanamycin resistance. For D344R and all its mutants, the MICs were as follows: vancomycin, 2 mg/liter (Etest); telavancin, <0.5 mg/liter (broth microdilution); linezolid, 0.75 to 1.0 mg/liter (Etest); and minocycline, 16 mg/liter (Etest).